Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 4, 1996, Pages 460-465

  Kawahara, Jun Ichi ^a   Izumi, Hideakira ^a   Okada, Yuji ^a   Izawa, Toshio ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

Ca2+ sensitivity; K+ channel opener; KRN4884; Levcromakalim; Nifedipine; Vasorelaxation

Indexed keywords

5 AMINO N [2 (2 CHLOROPHENYL)ETHYL] N' CYANO 3 PYRIDINECARBOXAMIDINE; CALCIMYCIN; GLIBENCLAMIDE; LEMAKALIM; NIFEDIPINE; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; MALE; NONHUMAN; RAT; VASODILATATION;

EID: 0029796905     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00168437     Document Type: Article

References (43)

1. Asano T, Hidaka H (1984) Vasodilatory action of HA 1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide]. a novel calcium antagonist with no effect on cardiac function. J Pharmacol Exp Ther 231:241-245
2. Best L, Bolton TB (1986) Depolarisation of guinea-pig visceral smooth muscle causes hydrolysis of inositol phospholipids. Naunyn-Schmiedeberg's Arch Pharmacol 333:78-82
3. Bray KM, Weston AH, Duty S, Newgreen DT, Longmore J, Edwards G, Brown T (1991) Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta. Br J Pharmacol 102:337-344
4. Buckingham RE, Hamilton TC, Howlett DR, Mootoo S, Wilson C (1989) Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol 97:57-64
5. 45Ca movements in rabbit aortic smooth muscle. Fur J Pharmacol 155:229-237
6. Chopra LC, Charles HCT, Jeremy PTW (1992) Direct action of BRL38227 and glibenclamide on intracellular calcium stores in cultured airway smooth muscle of rabbit. Br J Pharmacol 105:259-260
7. + channel opener cromakalim on the rabbit aorta: comparison with the calcium antagonist isradipine. Br J Pharmacol 95:741-752
8. Eltze M (1989) Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Eur J Pharmacol 165:231-239
9. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H (1981) Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 218:248-259
10. 2+ transients in guinea-pig coronary myocytes. J Physiol (Lond) 470:35-44
11. Hamilton TC, Weir SW, Weston AH (1986) Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 88:103-111
12. 2+ concentration and mechanical activity induced by noradrenaline in the rabbit mesenteric artery. Br J Pharmacol 104:227-233
13. Izumi H, Jinno Y, Kaneta S, Tanaka Y, Okada Y, Izawa T, Ogawa M (1995) Effect of KRN488, a novel K channel opener, on the cardiovascular system in anesthetized dogs: A comparison with levcromakalim, nilvadipine, and nifedipine. J Cardiovasc Pharmacol 26:189-197
14. + channel opener, KRN 4884, and related compounds in porcine coronary artery. Gen Pharmacol (in press)
15. Jinno Y, Kasai H, Ohta H, Nishikori K, Fukushima H, Ogawa N (1992) Contribution of cyclic GMP formation to KRN 2391-induced relaxation in coronary artery of the pig. Br J Pharmacol 106:906-909
16. Kühberger E, Kukovetz WR, Groschner K (1993) Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity. J Cardiovasc Pharmacol 21:947-954
17. Mon T, Yanagisawa T, Taira N (1990) Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries. Naunyn-Schmiedeberg's Arch Pharmacol 341:251-255
18. Murray JJ, Reed PW, Fay FS (1975) Contraction of isolated smooth muscle cells by ionophore A23187. Proc Natl Acad Sci USA 72:4459-4463
19. Nishimura J, Van Breemen C (1989) Direct regulation of smooth muscle contractile elements by second messengers. Biochem Biophys Res Commun 163:929-935
20. 2+ channel blocker, in canine coronary arterial smooth muscle. Eur J Pharmacol 218:259-264
21. 2+ sensitization by endothelin-1 in canine coronary artery. Jpn J Pharmacol 60:403-405
22. 2+ sensitivity of arterial smooth muscle. Arch Int Pharmacodyn Ther 326:33-51
23. 2+ in canine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 347:438-444
24. Okada Y, Yokoyama T, Jinno Y, Kashiwabara T, Izawa T, Fukushima H, Ogawa N (1993c) Vasorelaxant action of Ki 1769, a new pyridinecarboximidamide. in isolated porcine coronary artery. Eur J Pharmacol 241:177-181
25. Parker RB, Waud DR (1971) Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther 177:1-12
26. + channels? Trends Pharmacol Sci 14:332-337
27. 2+ mobilization. Eur J Pharmacol 200:239-249
28. + channel openers. diazoxide and cromakalim. and their inhibition by glibenclamide. J Pharmacol Exp Ther 250:261-271
29. Rasmussen H, Takuwa Y, Park S (1987) Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1:177-185
30. Rembold CM (1992) Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20:129-137
31. Ruzycky AL, Morgan KG (1989) Involvement of the protein kinase C system in calcium-force relationships in ferret aorta. Br J Pharmacol 97:391-400
32. Thoa NB, Costa JL, Moss J, Kopin IJ (1974) Mechanism or release of norepinephrine from peripheral adrenergic neurons by the calcium ionophores X-537A and A23187. Life Sci 14:1705-1719
33. Triggle CR, Grant WF, Triggle DJ (1975) Intestinal smooth muscle contraction and the effects of cadmium and A23187. J Pharmacol Exp Ther 194:182-190
34. 86Rb efflux in rat blood vessels. Br J Pharmacol 88:121-128
35. 2+. Br J Pharmacol 98:1303-1311
36. Winquist RJ, Heaney LA, Wallace AA, Baskin EP, Stein RB, Garcia ML, Kaczorowski GJ (1989) Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther 248:149-156
37. Yamagishi T, Yanagisawa T, Taira N (1992a) Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery. Biochem Biophys Res Commun 187:1517-1522
38. 2+ release in canine coronary artery. Naunyn-Schmiedeberg's Arch Pharmacol 346:691-700
39. + concentrations measured with fura-2. Br J Pharmacol 98:469-482
40. Yanagisawa T, Okada Y (1993) The structure-activity relationship of KRN2391 as an N-K hybrid. Cardiovasc Drugs Rev 11:94-115
41. 2+ sensitivity of contractile elements in coronary arterial smooth muscle. Am J Physiol 267:H614-H621
42. Yanagisawa T, Taira N (1980) Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance. Naunyn-Schmiedeberg's Arch Pharmacol 312:69-76
43. 2+ of contractile elements and inositol phosphate formation in porcine coronary artery. J Pharm Pharmacol 47:148-151